GREGORY T SCHIFFMAN
CIK 1239011 · Chief Financial Officer · last filed 2026-06-18
GREGORY T SCHIFFMAN is a Chief Financial Officer who has filed 92 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for FABC, was dated Jun 18, 2026. Across all open-market trades the lifetime net is −$562.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.36M
8
92
-$562.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FABC | Director | — | $2.48 | — | $0 | 1 | 2026-06-18 |
| StableX Technologies, Inc. (SBLX) Delisted | Director | — | $3.10 | — | $0 | 1 | 2025-10-31 |
| StableX Technologies, Inc. (AYRO) Delisted | Director | 107,400 | $7.08 | $760.4K | -$177.2K | 14 | 2024-12-02 |
| ABSI | Chief Financial Officer | 605,165 | $7.13 | $4.31M | $0 | 3 | 2023-03-03 |
| StableX Technologies, Inc. (DCAR) Delisted | Director | 6,329 | — | — | $0 | 2 | 2019-08-29 |
| IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2016-11-15 |
| STEM | Chief Financial Officer | 9,007 | $5.33 | $48.0K | $49.8K | 7 | 2016-04-18 |
| VNUS MEDICAL TECHNOLOGIES INC (VNUS) Delisted | Director | 5,000 | — | — | -$435.6K | 12 | 2009-06-17 |
Recent Filings
92 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-18 | FABC | Grant (A) | — | $0 | EDGAR |
| 2025-10-31 | StableX Technologies, Inc. (SBLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-02 | StableX Technologies, Inc. (AYRO) Delisted | Mixed | +79,868 | $0 | EDGAR |
| 2023-08-03 | StableX Technologies, Inc. (AYRO) Delisted | Sell (S) | −7,274 | -$5.9K | EDGAR |
| 2023-08-01 | StableX Technologies, Inc. (SBLX) Delisted | Notice (144) | −7,274 | -$5.9K | EDGAR |
| 2023-05-05 | StableX Technologies, Inc. (AYRO) Delisted | Sell (S) | −6,810 | -$3.3K | EDGAR |
| 2023-05-03 | StableX Technologies, Inc. (SBLX) Delisted | Notice (144) | −6,810 | -$3.3K | EDGAR |
| 2023-03-03 | ABSI | Grant (A) | — | $0 | EDGAR |
| 2023-02-03 | StableX Technologies, Inc. (AYRO) Delisted | Mixed | +108,573 | -$2.9K | EDGAR |
| 2022-12-21 | — | Mixed | +36,167 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.